首页|垂体癌诊断与治疗的研究进展

垂体癌诊断与治疗的研究进展

扫码查看
垂体癌(pituitary carcinoma)是一种较为罕见的侵袭性恶性肿瘤,可浸润邻近组织,包括海绵窦、骨、蝶窦等,且常规治疗无效.在没有恶性肿瘤组织学特征的情况下,只有出现脑、脊髓或全身转移时,才能证实垂体癌的存在.其生长快速、频繁复发、诊断延迟滞后、常规治疗效果不佳以及预后差等特点,使垂体癌的综合管理与治疗十分困难.本文通过对垂体癌诊治的最新研究进展进行综述,加强临床医生对该病的认识,尽可能提高患者的长期生存率.
Research progress in the diagnosis and treatment of pituitary carcinoma
Pituitary carcinoma(PC)is a rare invasive malignant tumor,which can invade adjacent tissues,including cavernous sinus,bone,sphenoid sinus,etc.,and it is ineffective to conventional treat-ment.Without histological features of malignant tumors,PC could be confirmed only when cerebrospinal or systemic metastases were present.Moreover,the characteristics of rapid growth,frequent recurrence,de-layed diagnosis,poor response to conventional treatment,and poor prognosis make it difficult to manage and treat synthetically.This article reviewed the latest progress in the diagnosis and treatment of pituitary carci-noma,so as to strengthen the clinicians'knowledge of the disease and improve the long-term survival rate of patients as much as possible.

Pituitary carcinomaTemozolomideTargeted therapyPeptide receptor radionuclide therapy

董文静、颜世举、赵健、谷伟军

展开 >

解放军医学院,北京 100039

解放军总医院海南医院骨科,三亚 572013

解放军总医院第一医学中心内分泌科,北京 100853

垂体癌 替莫唑胺 靶向治疗 肽受体放射性核素治疗

北京市自然科学基金面上基金项目

7232155

2024

国际内分泌代谢杂志
中华医学会,天津医科大学

国际内分泌代谢杂志

CSTPCD
影响因子:0.842
ISSN:1673-4157
年,卷(期):2024.44(4)
  • 2